CME Group
CME · NYSE · Financials · United States
Financials at a glance
Source: SEC XBRLAnnual
Quarterly · last 8
Revenue (FY2025)
$6.5B
Net margin
62.5%
ROE
14.2%
Revenue CAGR (2y)
+8.1%
Profit CAGR (2y)
+12.4%
EPS (FY2025)
11.16
Net profit (FY2025)
$4.1B
Ask MarketChacha about CME
Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.
Why it moved
- Sep 2, 2026
CME shares fell 3.03% in line with the broader market sell-off driven by rising oil prices (from U.S. strikes on Iran), higher Treasury yields, and increased odds of a near-term Fed rate hike.
- Jul 22, 2026
CME Group reported Q2 2026 results that beat estimates with record market data growth and strong H1 performance, per its July 22 8-K and multiple contemporaneous reports.
Daily moves with the verified reason behind them. Education only — not investment advice.
Financials
Yearly
| Period | Revenue | Net profit | EPS | Net margin | ROE |
|---|---|---|---|---|---|
| FY2025 | $6.5B | $4.1B | 11.16 | 62.5% | 14.2% |
| FY2024 | $6.1B | $3.5B | 9.67 | 57.5% | 13.3% |
| FY2023 | $5.6B | $3.2B | 8.86 | 57.8% | 12.1% |
Quarterly
| Period | Revenue | Net profit | EPS | Net margin |
|---|---|---|---|---|
| 2026Q2 | $1.7B | $1.0B | 2.88 | 61.1% |
| 2026Q1 | $1.9B | $1.2B | 3.18 | 61.4% |
| 2025Q3 | $1.5B | $908.0M | 2.49 | 59.1% |
| 2025Q2 | $1.7B | $1.0B | 2.81 | 60.6% |
| 2025Q1 | $1.6B | $956.2M | 2.62 | 58.2% |
| 2024Q3 | $1.6B | $912.8M | 2.50 | 57.6% |
| 2024Q2 | $1.5B | $883.2M | 2.42 | 57.6% |
| 2024Q1 | $1.5B | $855.2M | 2.35 | 57.5% |
| 2023Q3 | $1.3B | $750.2M | 2.06 | 56.1% |
| 2023Q2 | $1.4B | $777.6M | 2.14 | 57.2% |
| 2023Q1 | $1.4B | $883.8M | 2.43 | 61.3% |
Figures as reported, in reporting currency. Source: SEC XBRL.
Filings & announcements
2026
- SEC7/24/2026
- SEC7/22/2026material
- SEC6/17/2026material
- SEC6/10/2026material
- SEC5/19/2026material
- SEC4/27/2026material
- SEC4/24/2026
- SEC4/22/2026material
- SEC2/26/2026
- SEC2/4/2026material
- SEC2/2/2026material
2025
- SEC10/24/2025
- SEC10/22/2025material
- SEC9/11/2025material
- SEC7/25/2025
- SEC7/25/2025material
In the news
- Piper Sandler maintains Overweight on CME Group, lowers target to $295scanx.trade · 9/4/2026
- How Is CME Group's Stock Performance Compared to Other Financial Services StocksBarchart.com · 9/4/2026
- CME Group (CME) Plans New Equity Futures, Is The Stock Fully Valued?simplywall.st · 9/2/2026
- CME Group Inc. stock edges lower as derivatives activity growsAD HOC NEWS · 9/1/2026
- CME’s New Factor and Wind Futures Might Change The Case For Investing In CME Group (CME)simplywall.st · 8/31/2026
- CME Group (CME) Stock Looks Expensive After An 81% Five Year Runwebull.com · 8/30/2026
- CME Group Shares Gain 1.7% as Record Trading Volume Lifts Margin to 69.5%TechStock² · 8/29/2026
- Resilient CME Group stock trades close to $281 as Q2 2026 earnings highlight strong marginsAD HOC NEWS · 8/29/2026
Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.